IGFBP2 and preeclampsia: Therefore, the downregulation of IGFBP2 expression in the placental tissues of patients with preeclampsia may be associated with impaired invasive capacity of trophoblast cells and may lead to abnormal placental development by inhibiting the EMT process, thereby contributing to the pathogenesis of preeclampsia.